Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population

Table 4

Prevalence of metabolic syndrome in T2D and LADA.

	Ab^−T2D	Ab^+T2D	LADA
No metabolic syndrome N (%)	12 (10.4)	6 (46.2)	12 (85.7)
With metabolic syndrome N (%)	103 (89.6)	7 (53.8)	2 (14.3)

T2D: type 2 diabetes; LADA: latent autoimmune diabetes of the adults; Ab⁻T2D: autoantibody-negative cases in T2D group; Ab⁺T2D: autoantibody-positive cases in T2D group; N: number; value compared to Ab⁻T2D, value between Ab⁺ T2D and cases of LADA.